Compare Vaxcyte Inc. Common Stock (PCVX) vs Spotify Technology (SPOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Spotify Technology — how do they compare? Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.63B), while Spotify Technology trades at $519.75 (market cap $107.72B). The key difference: Spotify Technology is far larger — about 10.1× Vaxcyte Inc. Common Stock's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Spotify Technology nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Spotify Technology for 111 Days on average.
| PCVX | SPOT | |
|---|---|---|
Market Cap | $10.63B | $107.72B |
Volume | 1,525,205 | 1,447,333 |
Sector | Health | Media |
52-Week High | $73.82 | $689.21 |
52-Week Low | $40.32 | $412.75 |
Typical Hold Time | 0 Days | 111 Days |
Enterprise Value | $9.26B | $97.72B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Spotify (SPOT) trades at $527.45, down 0.26% with a bullish technical outlook. The company shows strong fundamental improvement with revenue growing from $11.7B in 2022 to $17.2B in 2025, while turning profitable with net income reaching $2.2B. Recent news highlights Spotify's expansion into health tech through founder Daniel Ek's Neko Health venture and new recommendation algorithm features.
The stock offers growth potential with 62% analyst buy ratings and a $588 consensus target, representing 11% upside. Key risks include recent earnings miss in Q2 2026 and competitive pressures in streaming. Positive cash flow trends and margin expansion support the bullish case, though investors should monitor Q3 2026 results due October 22.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Spotify Technology
Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →
